EUVIMEDEUVIMED entdecken
ÄquivalenzstudieRandomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effects of pregnancy and lactation prebiotics supplementation on infant allergic disease: A randomized controlled trial

Debra J Palmer, Alana R Cuthbert, Thomas R Sullivan, Rachelle A Pretorius, Johan Garssen, Kristina Rueter, Maria C Jenmalm, Jeffrey A Keelan, Desiree Silva, Susan L Prescott

Journal of Allergy and Clinical Immunology · 2025

DOI: 10.1016/j.jaci.2024.08.009 ↗

Kurz gefasst

Äquivalenzstudie in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025. Verfasst von Debra J Palmer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Telethon Kids Institute, The University of Western Australia, Nedlands, Australia; School of Medicine, The University of Western Australia, Crawley, …. Hauptthemen laut MEDLINE: Dietary Supplements, Lactation, Prebiotics. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Telethon Kids Institute, National Health and Medical Research Council, Nutricia Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Ingestion of prebiotics during pregnancy and lactation may have immunomodulatory benefits for the developing fetal and infant immune system and provide a potential dietary strategy to reduce the risk of allergic diseases. OBJECTIVE: We sought to determine whether maternal supplementation with dietary prebiotics reduces the risk of allergic outcomes in infants with hereditary risk. METHODS: We undertook a double-blind randomized controlled trial in which pregnant women were allocated to consume prebiotics (14.2 g daily of galacto-oligosaccharides and fructo-oligosaccharides in the ratio 9:1) or placebo (8.7 g daily of maltodextrin) powder from less than 21 weeks' gestation until 6 months postnatal during lactation. Eligible women had infants with a first-degree relative with a history of medically diagnosed allergic disease. The primary outcome was medically diagnosed infant eczema by age 1 year, and secondary outcomes included allergen sensitization, food allergy, and recurrent wheeze by age 1 year. RESULTS: A total of 652 women were randomized between June 2016 and November 2021 (329 in the prebiotics group and 323 in the placebo group). There was no significant difference between groups in the percentage of infants with medically diagnosed eczema by age 1 year (prebiotics 31.5% [103 of 327 infants] vs placebo 32.6% [105 of 322 infants]; adjusted relative risk, 0.98; 95% CI, 0.77-1.23; P = .84). Secondary outcomes and safety measures also did not significantly differ between groups. CONCLUSIONS: We found little evidence that maternal prebiotics supplementation during pregnancy and lactation reduces the risk of medically diagnosed infant eczema by age 1 year in infants who are at hereditary risk of allergic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary SupplementsLactationPrebioticsAdultFemaleHumansInfantInfant, NewbornMalePregnancyDouble-Blind MethodEczemaFood HypersensitivityHypersensitivityOligosaccharides

Stichwörter der Autor:innen

Allergy preventioneczemainfantlactationmaternal dietprebioticspregnancyrandomized controlled trial

Substanzen

OligosaccharidesPrebiotics

Autor:innen und Institutionen

  • Telethon Kids Institute, The University of Western Australia, Nedlands, Australia; School of Medicine, The University of Western Australia, Crawley, Australia. Electronic address: debbie.palmer@uwa.edu.au.
  • SAHMRI Women and Kids, South Australian Health and Medical Research Institute, Adelaide, Australia.
  • SAHMRI Women and Kids, South Australian Health and Medical Research Institute, Adelaide, Australia; School of Public Health, The University of Adelaide, Adelaide, Australia.
  • Telethon Kids Institute, The University of Western Australia, Nedlands, Australia; School of Medicine, The University of Western Australia, Crawley, Australia.
  • Division of Pharmacology Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands; Nutricia Research, Utrecht, The Netherlands.
  • School of Medicine, The University of Western Australia, Crawley, Australia; Department of Immunology and Dermatology, Perth Children's Hospital, Nedlands, Australia.

Förderung

  • Telethon Kids Institute
  • National Health and Medical Research Council
  • Nutricia Research Foundation
  • Danone Nutricia Research
  • DSM
  • European Commission

Zitieren

APA

Palmer, D. J., Cuthbert, A. R., Sullivan, T. R., Pretorius, R. A., Garssen, J., Rueter, K., Jenmalm, M. C., Keelan, J. A., Silva, D., & Prescott, S. L. (2025). Effects of pregnancy and lactation prebiotics supplementation on infant allergic disease: A randomized controlled trial. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2024.08.009

Vancouver

Palmer DJ, Cuthbert AR, Sullivan TR, Pretorius RA, Garssen J, Rueter K, et al. Effects of pregnancy and lactation prebiotics supplementation on infant allergic disease: A randomized controlled trial. Journal of Allergy and Clinical Immunology. 2025. doi:10.1016/j.jaci.2024.08.009

BibTeX
@article{Palmer2025,
  author = {Palmer, Debra J and Cuthbert, Alana R and Sullivan, Thomas R and Pretorius, Rachelle A and Garssen, Johan and Rueter, Kristina and Jenmalm, Maria C and Keelan, Jeffrey A and Silva, Desiree and Prescott, Susan L},
  title = {Effects of pregnancy and lactation prebiotics supplementation on infant allergic disease: A randomized controlled trial},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2025},
  doi = {10.1016/j.jaci.2024.08.009}
}
Kostenlos starten →